| Data resource profile: clinical practice research datalink (CPRD) E Herrett, AM Gallagher, K Bhaskaran, H Forbes, R Mathur, T Van Staa, ... International journal of epidemiology 44 (3), 827-836, 2015 | 2566 | 2015 |
| Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients AM Gallagher, E Setakis, JM Plumb, A Clemens, TP van Staa Thrombosis and haemostasis 106 (11), 968-977, 2011 | 491 | 2011 |
| Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? AM Gallagher, S Rietbrock, J Plumb, TP Van Staa Journal of Thrombosis and Haemostasis 6 (9), 1500-1506, 2008 | 291 | 2008 |
| Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care … M Yoon, PS Yang, E Jang, HT Yu, TH Kim, JS Uhm, JY Kim, JH Sung, ... Thrombosis and haemostasis 119 (10), 1695-1703, 2019 | 199 | 2019 |
| Fracture outcomes related to persistence and compliance with oral bisphosphonates AM Gallagher, S Rietbrock, M Olson, TP van Staa Journal of Bone and Mineral Research 23 (10), 1569-1575, 2008 | 177 | 2008 |
| Cancer recording and mortality in the General Practice Research Database and linked cancer registries R Boggon, TP van Staa, M Chapman, AM Gallagher, TA Hammad, ... Pharmacoepidemiology and drug safety 22 (2), 168-175, 2013 | 166 | 2013 |
| Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data TP Van Staa, D Patel, AM Gallagher, ML De Bruin Diabetologia 55, 654-665, 2012 | 149 | 2012 |
| Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001 AM Gallagher, JM Thomas, WT Hamilton, PD White Journal of the Royal Society of Medicine 97 (12), 571-575, 2004 | 120 | 2004 |
| Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’[CHADS2 score= 1]: simplifying stroke risk assessment and … GYH Lip Thrombosis and haemostasis 103 (04), 683-685, 2010 | 109 | 2010 |
| A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer … J Castellsague, JG Kuiper, A Pottegård, I Anveden Berglind, D Dedman, ... Clinical epidemiology, 299-310, 2018 | 107 | 2018 |
| Is the CPRD GOLD population comparable to the UK population? J Campbell, DJ Dedman, SC Eaton, AM Gallagher, TJ Williams Pharmacoepidemiology and Drug Safety 22, 280-281, 2013 | 88 | 2013 |
| Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes AM Gallagher, TP van Staa, T Murray-Thomas, N Schoof, A Clemens, ... BMJ open 4 (1), e003839, 2014 | 85 | 2014 |
| Linkage of the General Practice Research Database (GPRD) with other data sources AM Gallagher, S Puri, TP van Staa Pharmacoepidemiology and drug safety 20, S230-S231, 2011 | 80 | 2011 |
| Risk markers for both chronic fatigue and irritable bowel syndromes: a prospective case-control study in primary care WT Hamilton, AM Gallagher, JM Thomas, PD White Psychological medicine 39 (11), 1913-1921, 2009 | 66 | 2009 |
| The accuracy of date of death recording in the C linical P ractice R esearch D atalink GOLD database in E ngland compared with the O ffice for N ational S tatistics death … AM Gallagher, D Dedman, S Padmanabhan, HGM Leufkens, F de Vries Pharmacoepidemiology and drug safety 28 (5), 563-569, 2019 | 65 | 2019 |
| How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? S Rietbrock, JM Plumb, AM Gallagher, TP van Staa Thrombosis and haemostasis 101 (03), 527-534, 2009 | 60 | 2009 |
| Risk of fracture with thiazolidinediones: an individual patient data meta-analysis MT Bazelier, F De Vries, P Vestergaard, RMC Herings, AM Gallagher, ... Frontiers in endocrinology 4, 11, 2013 | 57 | 2013 |
| The prognosis of different fatigue diagnostic labels: a longitudinal survey WT Hamilton, AM Gallagher, JM Thomas, PD White Family Practice 22 (4), 383-388, 2005 | 54 | 2005 |
| Is the chronic fatigue syndrome an exercise phobia? A case control study AM Gallagher, AR Coldrick, B Hedge, WRC Weir, PD White Journal of psychosomatic research 58 (4), 367-373, 2005 | 50 | 2005 |
| Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data AM Gallagher, L Smeeth, S Seabroke, HGM Leufkens, TP van Staa PloS one 6 (12), e28157, 2011 | 42 | 2011 |
